Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
NYU Langone Health
National Cancer Institute (NCI)
University of South Florida
Duke University
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)